• CEO Fenton Markevich on the Importance of 340B

    President and CEO Fenton Markevich was recently featured in 340B Health’s 340B Chronicle, News from the 340B Health PAC. In this highlight, Fenton answered questions pertaining to his personal commitment and RxStrategies’ commitment to the 340B community and the 340B program, as well as the significance of contributing to the 340B Health PAC. Read the… Read more »

  • Ready to Connect at the 340B Coalition Summer Conference!

    RxStrategies is proud to be a Pinnacle Leader Sponsor of the 2017 340B Coalition Summer Conference, July 10-12. Our team will be connecting with industry leaders to gain insight and discuss the latest 340B Program developments during this highly attended conference. RxStrategies’ 340BPlus™ CompliancePlus (Self-Audit Tool), Dashboard Analytics, Contract Pharmacy, Split Billing and Specialty Pharmacy solutions are key to a… Read more »

  • Clinical Insights: June 2, 2017

    Welcome to the weekly edition of RxStrategies Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy market place.   New Drug Approval Rebinyn® (Coagulation Factor IX (Recombinant), GlycoPEGylated) – May 31, 2017 – Novo Nordisk announced that the U.S. Food and Drug Administration (FDA) has approved the Biologics License Application… Read more »

  • Let’s Connect at HCP 2017 Spring Hospital Pharmacy Conference!

      Rhodie Smith and John Braff will be representing RxStrategies at the HCP 2017 Spring Hospital Pharmacy Conference, May 1 – 3 in Los Angeles.   We are looking forward to connecting with Hospital Pharmacy Directors from America’s most prestigious hospitals and health systems during the Reverse Expo sessions. Stop by the Supplier Showcase Booth #1104 to… Read more »

  • Maximize Your Savings with Split Billing

    RxStrategies’ 340BPlus Split Billing Solution provides end-to-end 340B program management with a focus on program compliance. The 340BPlus Split Billing Solution takes the complexity out of 340B program management by reviewing all prescription activity to flag eligible 340B dispenses. All activity is then designated for proper replenishment, (GPO, WAC, 340B) auditability and reporting.    RxStrategies’ 340BPlus Split Billing… Read more »